mva-cmdr
Vaccineexperimental
Clinical trial activity
7 trials · 29 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2005 (NCT00376090)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva-cdmr
- mva-cmdr
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04301154 | Phase 1 | Jun 30, 2020 | Bambino Gesù Hospital and Research Institute, Case Western Reserve University, Chulalongkorn University, Government of Thailand, Henry M. Jackson Foundation for the Advancement of Military Medicine, Johns Hopkins University, Karolinska Institute, Leidos, PENTA Foundation, United States Army, University of Miami, University of Padova |
| NCT02296541 | Phase 1 | Dec 1, 2014 | Duke University, Harvard University, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne |
| NCT01889719 | Phase 1 | Jan 1, 2014 | Rockefeller University |
| NCT01697007 | Phase 2 | Nov 1, 2012 | Government of Mozambique, Karolinska Institute, Ludwig Maximilians University, Mbeya Referral Hospital, Tanzania, Medical Research Council, Muhimbili University, National Institute for Medical Research, Tanzania, Swedish Institute for Infectious Disease Control, United States Army, University of London |
| NCT01407497 | Phase 1 | Aug 1, 2011 | European and Developing Countries Clinical Trials Partnership (EDCTP), Government of Mozambique, Hospital Central de Maputo, Swedish Institute for Communicable Disease Control, Sweden |
| NCT01260727 | Phase 1 | Feb 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT00376090 | Phase 1 | Jul 1, 2005 | United States Army |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (29)
29 organizations
Page 1 / 2